Related Posts
ISN Journal summaries: effect of pravastatin on ADPKD and 10 years of Kidney International Reports®
Kidney International® A randomized controlled trial evaluated the effect of pravastatin on... read more
Taking the unknown out of CKDu: Read the new report from ISN i3C in Kidney International®
After two decades of research, the causes of chronic kidney disease of undetermined... read more
ISN Journal summaries on pediatric CKD outcomes and homelessness as a social determinant of kidney health
Kidney International® Establishing a core outcome measure for life participation in children... read more
Bridging global kidney care gaps through data: KI presents ISN-GKHA Interactive Map
A recent Kidney International® editorial showcases the ISN-Global Kidney Health Atlas (ISN-GKHA) Interactive Map, an open-access tool... read more
“Stay on top of the evidence base” — Adeera Levin on WCN’26 HIT sessions
At WCN’26, the high-impact trials (HIT) and late-breaking clinical trials (LBCT) sessions will show you what matters most for patient... read more
Research in action: How ISN committees are driving the future of kidney research — and how you can be part of it
Across the ISN’s research groups and committees, this year has been... read more
Rethinking kidney trials: The ISN’s PARADIGM roadmap moves into action
Kidney disease research is entering a pivotal moment. Kidney International® published... read more
ISN Journal summaries on felzartamab for IgA nephropathy and a new anti-podocin ELISA
Kidney International® Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and... read more
ISN Journal summaries on the DIALIZE-Outcomes trial and heat stress nephropathy in CKDu hotspots in India
Kidney International® The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis People... read more
CONFIDENCE trial: Dual therapy shows promise for CKD and diabetes
ISN-ACT Global Trials Focus (GTF) editorial team member Michele Provenzano summarizes... read more
